Comparison of mammosphere formation from stem-like cells of normal breast, malignant primary breast tumors, and MCF-7 cell line.

IF 2.1 Q3 ONCOLOGY
Jenifer Mallavarpu Ambrose, Vishnu Priya Veeraraghavan, Rosy Vennila, Secunda Rupert, Jeswanth Sathyanesan, Rajasundari Meenakshisundaram, Sakthivel Selvaraj, Sarubala Malayaperumal, Malathi Kullappan, Sudarsanam Dorairaj, Jayesh R Gujarathi, Sri Harshini Gandhamaneni, Krishna Mohan Surapaneni
{"title":"Comparison of mammosphere formation from stem-like cells of normal breast, malignant primary breast tumors, and MCF-7 cell line.","authors":"Jenifer Mallavarpu Ambrose,&nbsp;Vishnu Priya Veeraraghavan,&nbsp;Rosy Vennila,&nbsp;Secunda Rupert,&nbsp;Jeswanth Sathyanesan,&nbsp;Rajasundari Meenakshisundaram,&nbsp;Sakthivel Selvaraj,&nbsp;Sarubala Malayaperumal,&nbsp;Malathi Kullappan,&nbsp;Sudarsanam Dorairaj,&nbsp;Jayesh R Gujarathi,&nbsp;Sri Harshini Gandhamaneni,&nbsp;Krishna Mohan Surapaneni","doi":"10.1186/s43046-022-00152-1","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Mammosphere formation assay has become a versatile tool to quantify the activity of putative breast cancer stem cells in non-adherent in vitro cultures. However, optimizing the suspension culture system is crucial to establish mammosphere cultures from primary breast tumors.</p><p><strong>Methods: </strong>This study aimed at determining the self-renewal and sphere-forming potential of breast cancer stem-like cells derived from human primary invasive ductal carcinoma and normal breast tissue samples, and MCF-7 breast cancer cell line using an optimal suspension culture system. Mammosphere-forming efficiency of the mammospheres generated from the tissue samples and cell line were compared. We evaluated the expression of CD44<sup>+</sup>/CD24<sup>-</sup>/<sup>low</sup> and CD49f<sup>+</sup>/EpCAM<sup>-</sup>/<sup>low</sup> phenotypes in the stem-like cells by flow cytometry. CK-18, CK-19, α-SMA, and EpCAM marker expression was assessed using immunohistochemical staining.</p><p><strong>Results: </strong>Breast epithelial cells isolated from the three samples formed two-dimensional spheroids in suspension cultures. Interestingly, mammospheres formed from patient-derived primary breast tumors were enriched in breast cancer stem-like cells with the phenotype CD44<sup>+</sup>/CD24<sup>-</sup>/<sup>low</sup> and exhibited a relatively more number of large spheres when compared to the normal breast stem cells. MCF-7-derived SCs were more aggressive and resulted in the formation of a significantly higher number of spheroids. The expression of CK-18/CK-19 and α-SMA/EpCAM proteins was confirmed in breast cancer tissues.</p><p><strong>Conclusions: </strong>Thus, the use of primary tumor specimens and breast cancer cell lines as suitable models for elucidating the breast cancer stem cell activity was validated using mammosphere culture system.</p>","PeriodicalId":17301,"journal":{"name":"Journal of the Egyptian National Cancer Institute","volume":"34 1","pages":"51"},"PeriodicalIF":2.1000,"publicationDate":"2022-12-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"2","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of the Egyptian National Cancer Institute","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1186/s43046-022-00152-1","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 2

Abstract

Background: Mammosphere formation assay has become a versatile tool to quantify the activity of putative breast cancer stem cells in non-adherent in vitro cultures. However, optimizing the suspension culture system is crucial to establish mammosphere cultures from primary breast tumors.

Methods: This study aimed at determining the self-renewal and sphere-forming potential of breast cancer stem-like cells derived from human primary invasive ductal carcinoma and normal breast tissue samples, and MCF-7 breast cancer cell line using an optimal suspension culture system. Mammosphere-forming efficiency of the mammospheres generated from the tissue samples and cell line were compared. We evaluated the expression of CD44+/CD24-/low and CD49f+/EpCAM-/low phenotypes in the stem-like cells by flow cytometry. CK-18, CK-19, α-SMA, and EpCAM marker expression was assessed using immunohistochemical staining.

Results: Breast epithelial cells isolated from the three samples formed two-dimensional spheroids in suspension cultures. Interestingly, mammospheres formed from patient-derived primary breast tumors were enriched in breast cancer stem-like cells with the phenotype CD44+/CD24-/low and exhibited a relatively more number of large spheres when compared to the normal breast stem cells. MCF-7-derived SCs were more aggressive and resulted in the formation of a significantly higher number of spheroids. The expression of CK-18/CK-19 and α-SMA/EpCAM proteins was confirmed in breast cancer tissues.

Conclusions: Thus, the use of primary tumor specimens and breast cancer cell lines as suitable models for elucidating the breast cancer stem cell activity was validated using mammosphere culture system.

正常乳腺、恶性原发乳腺肿瘤和MCF-7细胞系干细胞样细胞形成乳腺球的比较
背景:乳腺球形成测定已经成为一种多功能的工具,用于量化非贴壁体外培养中假定的乳腺癌干细胞的活性。然而,优化悬浮培养系统对于建立原发乳腺肿瘤的乳腺球培养至关重要。方法:采用最优悬浮培养体系,检测从人原发性浸润性导管癌和正常乳腺组织样本中提取的乳腺癌干细胞样细胞和MCF-7乳腺癌细胞系的自我更新和成球潜能。比较了组织样品和细胞系生成的乳腺球的形成效率。我们用流式细胞术评估了CD44+/CD24-/low和CD49f+/EpCAM-/low表型在干细胞样细胞中的表达。免疫组化染色检测CK-18、CK-19、α-SMA、EpCAM标志物的表达。结果:从三个样品分离的乳腺上皮细胞在悬浮培养中形成二维球体。有趣的是,与正常乳腺干细胞相比,患者源性原发性乳腺肿瘤形成的乳腺球富含CD44+/CD24-/low表型的乳腺癌干细胞样细胞,并且显示出相对更多的大球。mcf -7衍生的SCs更具侵袭性,形成的球状体数量明显增加。证实CK-18/CK-19和α-SMA/EpCAM蛋白在乳腺癌组织中的表达。结论:乳球培养系统验证了将原发肿瘤标本和乳腺癌细胞系作为研究乳腺癌干细胞活性的合适模型的可行性。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
3.50
自引率
0.00%
发文量
46
审稿时长
11 weeks
期刊介绍: As the official publication of the National Cancer Institute, Cairo University, the Journal of the Egyptian National Cancer Institute (JENCI) is an open access peer-reviewed journal that publishes on the latest innovations in oncology and thereby, providing academics and clinicians a leading research platform. JENCI welcomes submissions pertaining to all fields of basic, applied and clinical cancer research. Main topics of interest include: local and systemic anticancer therapy (with specific interest on applied cancer research from developing countries); experimental oncology; early cancer detection; randomized trials (including negatives ones); and key emerging fields of personalized medicine, such as molecular pathology, bioinformatics, and biotechnologies.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信